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Risks Associated With Renal Dysfunction
in Patients in the Coronary Care Unit
Peter A. McCullough, MD, MPH, FACC, Sandeep S. Soman, MD, Shalin S. Shah, MD,
Stephen T. Smith, MD, FACC, Keisha R. Marks, BS, Jerry Yee, MD, Steven Borzak, MD, FACC
Detroit, Michigan
The purpose of this study was to quantify the impact of baseline renal dysfunction on
morbidity and mortality in patients in the coronary care unit (CCU).
BACKGROUND The presence of renal dysfunction is an established independent predictor of survival after
acute myocardial infarction and revascularization procedures.
METHODS
We analyzed a prospective CCU registry of 12,648 admissions by 9,557 patients over eight
years at a single, tertiary center. Admission serum creatinine was available in 9,544 patients.
Those not on long-term dialysis were classified into quartiles of corrected creatinine clearance,
with cut-points of 46.2, 63.1 and 81.5 ml/min per 72 kg. Dialysis patients (n ⫽ 527) were
considered as a fifth comparison group.
RESULTS
Baseline characteristics, including older age, African-American race, diabetes, hypertension,
previous coronary disease and heart failure, were incrementally more common across
increasing renal dysfunction strata. There were graded increases in the relative risk for atrial
and ventricular arrhythmias, heart block, asystole, development of pulmonary congestion,
acute mitral regurgitation and cardiogenic shock across the risk strata. Survival analysis
demonstrated an early mortality hazard for those with renal dysfunction, but not on dialysis,
for the first 60 months, followed by graded decrements in survival across increasing renal
dysfunction strata.
CONCLUSIONS Baseline renal function is a powerful predictor of short- and long-term events in the CCU
population. There is an early hazard for in-hospital and postdischarge mortality for those with
a corrected creatinine clearance ⬍46.2 ml/min per kg, but not on dialysis. (J Am Coll Cardiol
2000;36:679 – 84) © 2000 by the American College of Cardiology
OBJECTIVES

We and other investigators have shown a graded, independent risk of acute renal failure after a percutaneous coronary
intervention, coronary artery bypass graft surgery and other
cardiac events driven in part by baseline renal function, as
measured in a variety of ways (1–5). The consequences of
acute renal failure requiring dialysis include high rates of
in-hospital mortality and shortened long-term survival,
whether or not dialysis becomes permanent (2,6). In addition, baseline renal function measured as serum creatinine,
blood urea nitrogen (BUN) or corrected creatinine clearance
has been shown in multiple epidemiologic studies and
clinical trials to be an independent predictor of survival in
patients with acute myocardial infarction (AMI), acute
coronary syndromes and a variety of other cardiovascular
events (7–11). These investigations have been limited,
however, by the exclusion of patients with more advanced
renal insufficiency, including those receiving dialysis treatment. We sought to evaluate the independent risk of
baseline renal dysfunction on outcomes in patients in the
coronary care unit (CCU) across a broad range of cardiovascular diagnoses and the full spectrum of renal risk.
From the Henry Ford Health System, Department of Internal Medicine, Division
of Cardiovascular Disease, Division of Hypertension and Nephrology, and the Henry
Ford Heart and Vascular Institute, Detroit, Michigan. This study was internally
funded by the Henry Ford Heart and Vascular Institute and was presented in part at
the 71st Scientific Sessions of the American Heart Association, Dallas, Texas,
November 8 –11, 1998.
Manuscript received August 10, 1999; revised manuscript received March 1, 2000;
accepted April 13, 2000.

METHODS
Setting, data collection and follow-up. The Henry
Ford Hospital is a 903-bed tertiary-care center located in
the urban core of the Detroit metropolitan area and
receives patients whose care is provided primarily within
the Henry Ford Health System, a vertically integrated,
mixed-model, managed-care organization with an advanced information technology infrastructure (12–14).
The Henry Ford Hospital Cardiac Intensive Care Unit
Database was a registry in which every admission to this
16-bed CCU had clinical data (⬃250 discrete elements)
prospectively recorded on case report forms by trained
research assistants. Data collected from May 1, 1990 to
August 22, 1998 included baseline demographic data,
laboratory values and events occurring during the unit
stay, such as revascularization and complications. The
data collection period was stopped after discharge from
the unit, either to another floor or to home. Mortality
during the CCU stay was recorded prospectively. Vital
status was tracked on an annual basis using a multilayered
approach. This approach called for ascertainment of
future activity in the health system by the patient,
confirmation of death by identification matching with the
State of Michigan Death Certificate Registry or record of
a death on a later hospital admission within the health
system corporate data stores. Finally, for those not
identified with any of these means, the available internet
death identification service was used to confirm death
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Abbreviations and Acronyms
AMI ⫽ acute myocardial infarction
BUN ⫽ blood urea nitrogen
CHF ⫽ congestive heart failure
cCrCl ⫽ corrected creatinine clearance
CI
⫽ confidence interval
CCU ⫽ coronary care unit
ECG ⫽ electrocardiogram
LVH ⫽ left ventricular hypertrophy
RR
⫽ relative risk
UAP ⫽ unstable angina pectoris

primarily in a state other than Michigan. These data
strategies yielded a 99% overall vital status ascertainment
rate for patients followed after the first CCU admission
longitudinally over 27 ⫾ 28 months (minimum 0, maximum 100).
Assessment of baseline renal function. The data base was
augmented with merged data from laboratory tables to
obtain complete renal function data on 9,544 patients.
Patients not on dialysis were initially classified into four
quartiles based on serum creatinine in mg/dl (creatinine
cut-points of 0.9 mg/dl [79.6 mol/liter], 1.1 mg/dl [97.2
mol/liter], and 1.5 mg/dl [132.6 mol/liter]). Because of
the rules needed to assign quartiles for ties, there were
uneven numbers of patients in groups 1 to 4: n ⫽ 2,851; n ⫽
1,945; n ⫽ 2,262; and n ⫽ 1,961, respectively. Patients on
long-term dialysis (n ⫽ 527) were considered as a fifth
comparison group. In an exploratory analysis, seven tables
were created with these risk groups, and univariate and
multivariate relative risks (RRs) were calculated for the renal
risk quartiles by baseline serum creatinine. This analysis
showed an exposure–response relation between serum creatinine and risk, therefore justifying further investigation
with a better estimate of baseline renal function suitable for
division into quartiles. Because weight was not available in
the data base, the corrected creatinine clearance (cCrCl) was
used as the best measure of baseline renal function, as
follows (15):
cCrCl male ⫽ (140 ⫺ age yrs)/72
cCrCl female ⫽ 0.85 ([140 ⫺ age yrs]/72)

The cCrCl was found to be unimodal and normally
distributed. Therefore, patients were classified into quartiles at the cut-points of 46.2, 63.1 and 81.5 ml/min per
72 kg. Patients on long-term dialysis (n ⫽ 527) were
considered again as a fifth comparison group. Seven
tables were again created with these groups as the column
headings. There were no directional changes in the final
calculated univariate and multivariate RRs. On the basis
of the established validity of estimated creatinine clearance as a surrogate for glomerular filtration rate and its
frequency distribution in this data set, the investigators
decided to retain the cCrCl as the measure of baseline
renal function throughout the analysis (16 –18).
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Admitting diagnoses. The admitting diagnosis categories
were ranked according to their in-hospital mortality. The
order, from highest to lowest mortality, was the following:
coma, shock, noncardiac diagnoses, other cardiac diagnoses,
congestive heart failure (CHF), AMI, arrhythmias and
unstable angina pectoris (UAP). The diagnosis rank code
was then used in multivariate modeling to account for the
severity of illness on admission.
Outcome validation. Eleven arrhythmic, hemodynamic
and fatal outcomes were selected for validation with blinded
chart abstraction. A random sample (n ⫽ 20) from each
outcome category was chosen, and each record was compared against chart abstraction for the development of the
outcome during the CCU stay. Agreement statistics were
computed for each outcome and then averaged over the 12
categories. The mean percent agreement was 92.7% across
the eleven outcomes.
Statistical analysis. Baseline characteristics are reported
as the mean value ⫾ SD or as proportions with the 95%
confidence interval (CI), as appropriate, with exclusion of
missing data points. Univariate comparisons were done
using analysis of variance or the chi-square test, as
appropriate. The chi-square test for linear trend was used
for comparisons of baseline characteristics across ascending levels of renal dysfunction. Multiple logistic regression analysis was performed for the outcomes of arrhythmic and hemodynamic complications, in-hospital death
and cumulative death, with independent RR and 95%
CIs. All models were tested for interactions. Variables in
the causal pathway were included in the final models. The
Cox proportional hazards model was used to derive the
independent hazard of estimated renal function with
cumulative, long-term survival. The log-rank test was
used to evaluate the independent differences in survival
across the strata. All p values are two-tailed and considered significant at alpha ⬍0.05.

RESULTS
Baseline characteristics. The overall mean age was 63.4 ⫾
13.8 years (range 15 to 98). The mean age for women and
men was similar— 63.6 ⫾ 13.8 and 63.3 ⫾ 13.7 years (p ⫽
0.22). The overall female/male ratio was 0.73, with male
gender predominant in all groups. For the study group as a
whole, 5,080 (53.2%) were white; 4,189 (43.9%) were
African-American; and 275 (2.9%) were categorized as
“other race.” African-American race increased in proportion
from group 1 to 5, including 60% of those on long-term
dialysis. Diabetes and hypertension were more common
across the ascending risk groups 1 to 5 (p ⬍ 0.0001 for both
trends). In contrast, smoking and hyperlipidemia were more
common in the lower risk group (p ⬍ 0.0001 for both
trends). Previous coronary artery disease increased only
slightly over the renal strata, from 27% to 37% for a history
of angina and from 20.6% to 31.7% for a previous AMI
(p ⬍ 0.0001 for both). Rates of previous coronary revascu-
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larization were similar among the groups. There was,
however, a graded increase from 13.8% to 45.0% in the
frequency of previous CHF from group 1 to 5 (p ⬍ 0.0001).
Rates of CHF medications, including angiotensinconverting enzyme inhibitors, diuretics and digoxin, also
increased over the strata, consistent with the CHF and
hypertension frequencies observed. A history of atrial fibrillation (either chronic or paroxysmal) was collected only in a
later group of patients (n ⫽ 373), from April 1, 1997 to
August 22, 1998, and the frequencies for renal risk groups 1
to 5 were 3.0% (4/130), 8.0% (6/75), 9.2% (7/76), 11.3%
(9/80) and 12.5% (1/8) (p ⫽ 0.26 for group 1 vs. 5, p ⫽ 0.05
for trend).
Admission clinical findings and diagnoses. Patients in
group 5 were more likely to be admitted with CHF
(23%), with the expected physical examination findings
of an S3 (22.0%), rales (38.9%) and peripheral edema
(21.8%). There were increasing levels of blood pressure
and heart rate across the renal risk strata (both p ⬍
0.0001). In addition, there were higher rates of atrial
fibrillation, complete heart block and bundle branch
blocks on the admission electrocardiogram (ECG) across
the renal risk strata (all p ⬍ 0.0001). Left ventricular
hypertrophy (LVH) by ECG criteria was present in
18.5% of group 5 as compared with 7.1% of group 1 (p ⬍
0.0001), consistent with the prevalence of hypertension
across these groups. Finally, as expected, there were
higher levels of baseline potassium, serum creatinine and
BUN on admission laboratory tests across the groups
(mean serum creatinine levels for groups 1 to 5: 0.8 ⫾
0.2, 1.0 ⫾ 0.2, 1.2 ⫾ 0.2, 3.0 ⫾ 2.8 and 4.9 ⫾ 3.7 mg/dl,
(respectively). Hemoglobin was found to be significantly
lower across the groups, with a mean hemoglobin level of
10.6 ⫾ 2.3 g/dl in the group on long-term dialysis.
Myocardial injury and left ventricular impairment. Confirmed myocardial infarction was less common in the higher
renal risk groups— 44.2% of all patients with confirmed
AMI in group 1 versus 21.8% of those in group 5 (p ⬍
0.0001). For those who had myocardial injury, the mean
peak creatine kinase values were lower in group 5 versus
group 1— 845.3 ⫾ 1,242.3 versus 1,188.3 ⫾ 1,527.4 U/liter
(p ⬍ 0.0001). Evidence for left ventricular dysfunction was
more common in the higher renal risk strata, with the
majority of those in groups 4 and 5 having cardiomegaly and
reduced left ventricular function as measured by echocardiography or radionuclide ventriculography. These observed
proportions are higher than the expected values, given the
fact that left ventricular function measurement was more
likely to be performed in those with clinical CHF or
suspected left ventricular dysfunction.
Tachyarrhythmias. There were graded increases in the
adjusted risk for atrial fibrillation, accelerated idioventricular
rhythm, sustained ventricular tachycardia and ventricular
fibrillation across the groups. There was no clear risk pattern
seen for levels of renal dysfunction and nonsustained ventricular tachycardia.

McCullough et al.
Renal Dysfunction in the Coronary Care Unit

681

Figure 1. Relative hazard for cumulative death after discharge from a
coronary care unit. A history (Hx) of heart failure is the greatest
independent hazard among dichotomous variables. The level of renal
function risk is the most important independent factor. *p ⬍ 0.00001.
**p ⫽ 0.0001. ***p ⬍ 0.03. ACEI ⫽ angiotensin-converting enzyme
inhibitor use before admission; ASA ⫽ aspirin use before admission; BB ⫽
beta-blocker use before admission; Dx severity ⫽ cardiac intensive care unit
admission diagnosis severity rank; Hb ⫽ hemoglobin in g/dl.

Bradyarrhythmias. There was a clear relation seen between
the level of renal dysfunction and the development of
complete heart block (adjusted RRs for groups 2 to 5: 1.73,
2.73, 2.82 and 3.64, respectively, p ⬍ 0.0001). A similar
pattern was seen for the level of renal dysfunction and the
development of asystole (adjusted RRs for groups 2 to 5:
1.75, 1.57, 2.80 and 2.36, respectively, p ⫽ 0.05).
Hemodynamic complications and death. In a graded
fashion, group 5 had the highest adjusted risk of developing
acute mitral regurgitation and pulmonary edema, as compared with group 1 (adjusted RR 3.80, 95% CI 1.78 to 8.14,
p ⫽ 0.0006). However, with cardiogenic shock and inhospital death, there was increased risk from groups 1 to 4
(adjusted RR 2.61, 95% CI 1.69 to 4.03, p ⬍ 0.0001), and
then a much lower adjusted risk in the group on long-term
dialysis (adjusted RR 1.70, 95% CI 0.84 to 3.46, p ⫽ 0.14).
Patients with AMI, heart failure or arrhythmia as the
principal diagnosis displayed relations of risk across the
renal strata (all p ⬍ 0.05). Only group 4 displayed an
increased risk of death in unstable angina and shock (RR
3.40, 95% CI 1.49 to 7.77, p ⫽ 0.003 and RR 5.29, 95% CI
1.40 to 20.02, p ⫽ 0.009). Risk assessments could not be
made for other cardiac diagnoses or coma because of small
cell sizes.
Long-term survival. Figure 1 displays the adjusted relative
hazard of cumulative death over long-term follow-up. Patients on dialysis had the greatest adjusted risk over the
follow-up period. Again, there was a clear, graded and
independent relation between the calculated cCrCl strata on
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Figure 2. Survival analysis of 9,544 consecutive patients admitted to a CCU and stratified by baseline cCrCl in ml/min per 72 kg. Proportional hazards
have been adjusted for age, gender, race, admission diagnosis, history of heart failure, previous aspirin, beta-blocker and angiotensin-converting enzyme
inhibitor use, diabetes and baseline hemoglobin in g/dl. This demonstrates an early mortality hazard within five years after discharge for individuals with
cCrCl ⱕ46.2 ml/min per 72 kg but not on dialysis, as compared with those on dialysis (p ⬍ 0.05 for comparisons of groups 3 to 5 versus groups 1 and 2).

CCU admission and long-term death. A history of heart
failure had the single greatest risk as a binary predictor
variable. Previous use of aspirin and beta-blockers had a
protective effect. A higher baseline hemoglobin level (g/dl)
was also independently associated with a reduced risk of
death over the long term.
Figure 2 displays the adjusted survival curves stratified by
renal dysfunction. Groups 3 to 5 had worsened survival as
compared with groups 1 and 2 (p ⬍ 0.05, by the log-rank
test). Group 4 had the worst survival for the first 60 months
until its survival curve is crossed by group 5 (patients on
long-term dialysis), who displayed an overall mortality rate
of 60% during the follow-up period. Mortality rates for the
subgroup of patients with a discharge diagnosis of AMI (Q
wave and non–Q wave combined), over a mean follow-up
period of 27.1 months (n ⫽ 4,035), were 14.6%, 22.7%,
30.5%, 54.3% and 65.0% for groups 1 to 5, respectively (p ⬍
0.0001).

DISCUSSION
Renal dysfunction as a risk for morbidity and mortality. This study has shown that a surrogate for baseline
renal function— cCrCl in ml/min per 72 kg—stratified
patients entering the CCU with a variety of diagnoses,
with respect to in-hospital complications and long-term
survival. Through a range of “normal” serum creatinine

levels— 0.8 ⫾ 0.2 mg/dl (70.7 ⫾ 17.7 mol/liter) to
1.2 ⫾ 0.2 mg/dl (106.1 ⫾ 17.7 mol/liter) in groups 1 to
3, there are measurable, graded increases in risk. At the
highest level of renal dysfunction not yet requiring
dialysis, the risk appears to be the greatest for many
adverse outcomes.
There were significant ethnic differences across the
renal risk groups, with higher proportions of AfricanAmericans in the higher risk groups— 60% on long-term
dialysis versus 37.6% in the lowest risk group. The impact
of baseline comorbidities across the renal strata was
evident. Those patients on long-term dialysis had, as
expected, significantly higher rates of diabetes, hypertension and CHF. Patients with renal dysfunction were
more likely to be admitted with CHF than with acute
ischemic syndromes. Although measurement of left ventricular function was not done routinely in patients, when
it was evaluable by indexes such as cardiothoracic ratio,
echocardiography, or radionuclide ventriculography, it
was lower in the higher risk strata, consistent with higher
rates of a history and admission diagnosis of CHF. The
multivariate analysis, however, indicates that not all the
risk observed in the upper strata can be explained by
decreased left ventricular function alone. Another confounder— baseline hemoglobin—was found to be lower
as renal failure advanced across the groups. This finding
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is consistent with the anemia associated with renal
dysfunction and was appropriately accounted for in all of
the multivariate analyses of this group. We did not record
the rates of transfusions in each group, as this would have
been unlikely to affect overall mortality rates (19).
Potential mediators of renal risk. This study suggests
that there are other unmeasured intermediate factors
present that mediate risk for arrhythmias, hemodynamic
problems and death. Candidate biologic and clinical
mechanisms include the presence of LVH, diastolic
dysfunction, adverse pharmacologic interactions, endothelial dysfunction, chronic volume overload and more
aggressive atherosclerosis related to increases in serum
homocysteine (20 –23).
Impact of dialysis. We found an early hazard with respect
to survival for those with a reduced cCrCl ⬍46.2 ml/min
per 72 kg, but not yet on dialysis. This suggests that dialysis
therapy, whether by selection or biologic action, has at least
a stabilizing effect on mortality in the first five years after
discharge. In the AMI subset of patients on dialysis, our
observed mortality rate at two years of 65% was consistent
with the results recently reported by Herzog et al. from the
U.S. Renal Data System (24).
Study limitations. We and other investigators have shown
the extraordinary high risk of in-hospital death for those
placed on short-term dialysis therapy after a percutaneous
intervention or open-heart surgery and in the medical
intensive care unit (2–5). This risk is almost certainly
mediated by multiorgan system failure and not by the
dialysis therapy alone (2). Although initiation of dialysis was
not an event captured in our registry, we expect this factor
may have influenced group 4, a predialysis group, but not
the other groups, where new dialysis was an unlikely clinical
issue.
In-hospital mortality rates do not reflect deaths in the
emergency room or in patients who were transferred to
long-term care facilities where the intent was terminal care.
In addition, we did not capture the advanced directives of
the patients in the data base, hence variations in the
frequency and determinants of in-hospital mortality are
inherent in this study.
Finally, we did not perform a detailed analysis of the
interactions between renal risk and complications related to
in-hospital procedures or other forms of therapy. These
interactions are known to be clinically important and
deserve future epidemiologic and prospective investigation.
Conclusions. Baseline cCrCl derived from serum creatinine, age and gender is a significant, independent risk factor
for acute arrhythmic and hemodynamic complications during CCU stays. Furthermore, renal risk stratification can
identify groups with high rates of in-hospital death and
poor long-term survival. This risk is only partially explained
by comorbidities, including diabetes, age and CHF. We
conclude that renal function is integrally related to survival
after a variety of cardiac events and that further research into
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the clinical and biologic mechanisms for this relation is
warranted.
Reprint requests and correspondence: Dr. Peter A. McCullough, Cardiovascular Division, Henry Ford Hospital, Henry Ford
Heart and Vascular Institute, William Clay Ford Center for
Athletic Medicine, 6525 Second Avenue, Detroit, Michigan
48202. E-mail: pmc975@yahoo.com.
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